IRISBIO OÜ is a OÜ based in Pärnu linn, registry code 16515447, status: active. Main activity: Research and experimental development on natural sciences and engineering. According to EMTA, turnover for Q3 2026 was €0 with 3 employees.
Turnover
0 €
State taxes
45 847 €
Labour taxes
48 670 €
↑ 112.1%vs Q2 2026
Employees
3
−1vs Q2 2026
Q3 2026 · data from the Tax and Customs Board (EMTA)
Position in the industry Scientific research and development · EMTAK 72
Labour taxes per employee16 223 €
above 98% of companies
industry median 2 218 € · companies in the industry: 234
Revenue · 20250 €
above 5% of companies
industry median 0 € · companies in the industry: 1 073
Taxes and turnover
Q4 2023 – Q3 2026
Turnover, € Q3 2026: 0 € · industry median 14 442 € · above 2% of the industry
Company
Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
Labour taxes per employee, € Q3 2026: 16 223 € · +182.9% vs Q2 2026 · industry median 2 218 € · above 98% of the industry
Company
Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
Revenue, € 2025: 0 € · industry median 0 € · above 5% of the industry
Company
Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
Net profit, € 2025: 952 € · −58.4% vs 2024 · industry median 0 € · above 64% of the industry
Company
Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
Net profit margin, % 2023: 31.2 % · −67.0 pp vs the year before · industry median 16.8 % · above 60% of the industry
Company
Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
Assets, € thousand 2025: 224 740 € · −44.8% vs 2024Equity, € 2025: 13 777 € · +7.4% vs 2024Employees2025: 5 · +66.7% vs 2024 · industry median 1 · above 75% of the industry
Company
Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
Financials by year
Year
Revenue, €
Net profit, €
Labour costs, €
Assets, €
Equity, €
Employees
2025
0
952
288 994
224 740
13 777
5
2024
0
2 291
135 308
407 069
12 825
3
2023
14 400
4 499
4 429
151 423
10 534
0
2022
3 600
3 535
—
6 035
6 035
0
Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.
Financial ratios for 2025
Return on equity (ROE)
6.9 %
Net profit / equity
Return on assets (ROA)
0.4 %
Net profit / assets
Equity ratio
6.1 %
Equity / assets
Debt ratio
93.9 %
Liabilities / assets
Current ratio
0.70
Current assets / current liabilities
Revenue per employee
0 €
Revenue / average full-time employees
Labour cost per employee per month
4 817 €
Labour costs / employees / 12 months (incl. employer taxes)
